How to improve the patient ADHERENCE to clinical trials ?

Slides:



Advertisements
Similar presentations
RARE Networking Webinar: “Improving Care Transitions for Patients with Mental Illnesses and Substance Use Disorders” Speakers: Paul Goering, MD Allina.
Advertisements

TRI science addiction Lost Opportunity? SBI for Substance Abuse In ERs and Trauma Centers Academy Health Mady Chalk, Ph.D. Treatment Research Institute.
Wendy Jones, 2005, National Center for Cultural Competence, based on categories by Rima Rudd, 2002, National Center for Adult Learning and Literacy Literacy.
Galveston County Health District 4Cs Clinics Summary Needs Assessment for 5 Year Competitive Grant And 4Cs Healthcare Barriers.
Managing the Mental Health Merry Go Round Karalyn Huxhagen B Pharm FPS AACPA.
PATIENT EDUCATION: Patient Empowerment Maria A. Marzan, MPH Principle Associate, Family Medicine Associate Director, ICM.
Medication Therapy Management The Patient and Provider Variables.
Introduction Medication non adherence ( noncompliance) remains a major problem. You have to assess and treat adherence related problems that can adversely.
Ask Me Anything American Nurses Training Association.
+ HEALTH INSURANCE: UNDERSTANDING YOUR COVERAGE Navigator Name Blank County Extension UGA Health Navigators.
ARV Nurse Training, Africaid, 2004 ARV Nurse Training Programme Marcus McGilvray & Nicola Willis Adherence.
Lecture 3: Health Psychology and Physical Illnesses I (Part 2)
Optimizing Patient Adherence to Pharmaceutical Care Plans 1.
Psychological Aspects of Oncology Patient “Contributing Factors & Intervention” Elham Abd El-Kader Fayad Professor of Psychiatric & Mental Health Nursing.
Promoting Adherence in Children. What are the challenges faced by children that interfere with ART adherence? B ased on your knowledge and experience,
RN SYSTEM WIDE EDUCATION PRESENTED BY S. FERGUSON, T. DILLON, L. LOCK, J. HASBUN, S. SHAH & R. GAINES Shepherd’s Hope.
Concordance Monica Arora © Swindon/Bath GPR Day Release Course 2006.
Obtaining THE BEST POSSIBLE MEDICATION HISTORY
Patient Compliance With Medical Advice. Patient compliance (patient adherence) :  The extent to which the patient adheres to medical advice Patient compliance.
The Integrated Behavioral Health Service Tiffany Cummings, M.S., Natasha Mroczek, M.S., & Thom Harrell, Ph.D. School of Psychology Florida Institute of.
Component 4: Education for a Partnership in Asthma Care The goal of all patient education is to help patients take the actions needed to control their.
Clinical Training: Medication Reconciliation
1 Meeting with Contacts for TB Assessment. Learning Objectives After this session, participants will be able to: 1.Explain why contact assessments are.
Medication Management – Tapping the Pharmacist’s Expertise for Employees with Multiple Medications Rosemarie Patodia, BScPhm, CGP Pharmacist, Manager,
+ Module Four: Patient/Family Education and Self-Management At the end of this module, the participant will be able to: Describe three learning needs of.
Treating Depression in the Elderly A Multi-disciplinary Approach 12/11/2003.
Implementing NICE guidance
1 Lecture 9: Adherence in ARV Therapy delivered by Dr. Ndwapi Ndwapi, BHP KITSO AIDS Training Program.
Following Your Treatment Plan. Taking your medication is an important part of your treatment. 2.
1 First Clinic Visit for Patients with HIV Infection HAIVN Harvard Medical School AIDS Initiative in Vietnam.
1 How to Talk To Your Doctor Marj Bernstein & Cathie Duncan Bridges Program.
1 Assessing and Improving ARV Adherence HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Education & Training Curriculum on Multiple Chronic Conditions (MCC) Strategies & tools to support health professionals caring for people living with MCC.
Medication Adherence The following module is designed as a basic overview of medication adherence for providers of healthcare, particularly those in a.
Introduction: Medical Psychology and Border Areas
SETMA Provider Training October 19, One of the catch phrases to medical home is that care is coordinated. At SETMA it means more than just coordinating.
1 Care for Injection Drug Users (IDUs) with HIV HAIVN Havard Medical School AIDS Initiative in Vietnam.
Care Management 101 Governor's Office of Health Care Reform October 28, 2010 Cathy Gorski, RN, BS, CCM.
SUSAN C DAY, MD, MPH Director of Quality and Practice Improvement Division of General Internal Medicine University of Pennsylvania CFHA Presentation: Integrating.
Special Populations in College Counseling Lippincott & Lippincott Physical Disabilities Presented by: Karen Cooper Samuel Lopez Allison Subasic.
Adherence Preparing to start ARVs Dr. Kevin M Harvey MBBS, MPH (UWI), Dip. ID (Lon.) Treatment care and support 2006.
The Integrated Behavioral Health Service Tiffany Cummings, M.S., Natasha Mroczek, M.S., & Thom Harrell, Ph.D. School of Psychology Florida Institute of.
Drug Adherence and Strategies for Compliance Assist. Prof. Dr. Memet IŞIK Ataturk University Medical Faculty Department of Family Medicine
7th Grade 7.MEH.3.1. Objective 3.1  Identify resources that would be appropriate for treating common mental disorders.
Section V Mental Health and Social Service Needs Unit 1: Psychosocial Needs of Residents.
Chapter 12 Recall Systems Copyright © 2011, 2006 Mosby, Inc., an affiliate of Elsevier. All rights reserved.
Elsevier items and derived items © 2009 by Saunders, an imprint of Elsevier Inc. 1 Chapter 9 Patient Teaching for Health Promotion.
Readmissions Driver Diagram OHA HEN 2.0. Readmissions AIMPrimary Drivers Secondary DriversChange Ideas Reduce Readmissions Identify patients at high-risk.
The DOT-Qualified Substance Abuse Professional (SAP) William “Reggie” Smith, MPA, CEAP, SAP.
“Focusing on the Process” Jeff Schmidt MD.  Recommendation #1: Children ages 4-18 who present with academic underachievement, behavior problems or.
Carol A. Miller, MD Professor, Pediatrics UCSF Benioff Children’s Hospital And the Asthma Task Force Team.
Introduction 2. Pharmaceutical care is a professional patient care practice, which, when provided as an organized service, is experienced, documented,
Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director.
Communicating with Patients and Providers HIV Care and ART: A Course for Pharmacists.
Adult Asthma Working with Adult Medicaid Clients.
Introduction to Mental Health Nursing MENTAL HEALTH AND MENTAL ILLNESS Mental health and mental illness are difficult to define precisely. People who can.
Best Practices and Compliance
PATIENT COUNSELLING.
Prescribing.
Module 4: Role Playing and Case Discussions
Patient Teaching and Health Literacy
Introduction to Clinical Pharmacy
Compliance & Non-Compliance
PATIENT MEDICATION ADHERENCE
Developing an Effective Assisted Outpatient Treatment Program
Treating Alcohol Abuse
Provider and Member Education in Managed Care Pharmacy
Chapter 9: Community Pharmacy
Supporting a family member or friend living with mental illness
Communication Skills Interviewing and assessment By Dr. Vian Ahmed
Presentation transcript:

How to improve the patient ADHERENCE to clinical trials ?

??????????? IS THE VISIT ADHERENCE A CONSECUENCE OF THE MEDICATION ADHERENCE?

ADHERENCE CONCEPTS AND TERMINOLOGY Compliance, adherence, and persistence are all terms commonly used in the literature to describe medication-taking behaviors. Adherence to, or compliance with, a medication regimen is generally defined as the extent to which a person takes medications as prescribed by their health care providers..

Adherence has become the preferred term, defined by the World Health Organization as: “the extent to which a person’s behavior [in] taking medication…corresponds with agreed recommendations from a health care provider” (World Health Organization, 2003).

The term compliance has come into disfavor because it suggests that a person is passively following a doctor’s orders, rather than actively collaborating in the treatment process. Adherence, on the other hand, requires the person’s agreement to the recommendations for therapy

Persistence is defined as the ability of a person to continue taking medications for the intended course of therapy.

In the case of chronic diseases, the appropriate course of therapy may be months, years, or even the person’s lifetime. A person is classified as non- persistent if he or she never fills a prescription or stops taking a prescription prematurely.

Discussing the intended course of therapy when medications are first started has been shown to be an important factor in keeping people persistent with a medication regimen.

1.SOCIAL AND ECONOMIC DIMENSION Limited language proficiency Low health literacy Lack of family or social support network Unstable living conditions; homelessness Burdensome schedule Limited access to health care facilities Lack of health care insurance Inability or difficulty accessing pharmacy Medication cost Cultural and lay beliefs about illness and treatment Elder abuse

2. HEALTH CARE SYSTEM DIMENSION Provider-patient relationship Provider communication skills (contributing to lack of patient knowledge or understanding of the treatment regimen) Disparity between the health beliefs of the health care provider and those of the patient Lack of positive reinforcement from the health care provider Weak capacity of the system to educate patients and provide follow-up Lack of knowledge on adherence and of effective interventions for improving it Patient information materials written at too high literacy level Restricted formularies; changing medications covered on formularies High drug costs, copayments, or both Poor access or missed appointments Long wait times Lack of continuity of care

3. CONDITION-RELATED DIMENSION Chronic conditions Lack of symptoms Severity of symptoms Depression Psychotic disorders Mental retardation/developmental disability

4. THERAPY-RELATED DIMENSION Complexity of medication regimen (number of daily doses; number of concurrent medications) Treatment requires mastery of certain techniques (injections, inhalers) Duration of therapy Frequent changes in medication regimen Lack of immediate benefit of therapy Medications with social stigma attached to use Actual or perceived unpleasant side effects Treatment interferes with lifestyle or requires significant behavioral changes

5. PATIENT-RELATED DIMENSION Physical Factors Visual impairment Hearing impairment Cognitive impairment Impaired mobility or dexterity Swallowing problems Psychological/Behavioral Factors Knowledge about disease Perceived risk/susceptibility to disease Understanding reason medication is needed Expectations or attitudes toward treatment Perceived benefit of treatment Confidence in ability to follow treatment regimen Motivation Fear of possible adverse effects Fear of dependence Feeling stigmatized by the disease Frustration with health care providers Psychosocial stress, anxiety, anger Alcohol or substance abuse

OUR ESTRATEGIES FOR MAINTAINING STUDY VISIT ADHERENCE TEAM WORK CALL CENTER/ FRECUENTLY PATIENTS PHONE CALLS

MAINTAINING STUDY VISIT ADHERENCE A participant may miss a visit either because they forgot about the visit or they refuse to attend a visit.

If the Participant Forgot to Attend a Visit: What to do: If a participant forgets to attend the visit, please reschedule the visit as soon as possible.

Helpful hints on how to keep participants from forgetting their visits: Call the participant two days prior to their scheduled visit to remind them of the date and time of the visit. Send the participant a post card informing them of the date and time of the visit. Try to keep the date and time of the visits at relatively the same time (e.g., the 10 th of every fourth month at 8:00 am).

The Participant Refuses to Attend a Visit: If a participant refuses to attend a visit, the site must determine the reason why the participant does not want to attend and try to work out a plan with the participant so that he/she still may continue to be followed.

The Participant Refuses to Attend a Visit: Once adequate follow-up is assured, the participant should be encouraged to resume taking their study drugs at the recommended doses

TIPS IN THE MEDICAL HISTORY WE SHOULD HAVE AT LEAST THREE TELEPHONES NUMBERS THE SUBJECTS AND RELATIVES SHOULD COME TO THE SCHEDULED VISIT AND IT IS VERY IMPORTANT THAT WE EXPLAIN THEM THE IMPORTANCE AND BENEFITS TO ASSIST TO ALL MEDICAL APPOINTMENTS

TIPS EVERY SCHEDULE VISIT WE SHOULD CHECK IF THE SUBJECT HAS THE SAME TELEPHONES NUMBERS SAND IF HE/SHE DID NOT MOVE TO ANOTHER HOME ! ITS VERY IMPORTANT NOTIFY TO THE PATIENT THAT WHEN HE/SHE WILL MOVE PLEASE MAKE A PHONE CALL TO US TO CHANGE THE PHONE NUMBER AND THE ADDRESS REGISTERED !

How to Find a Lost Participant Send letter via registered mail Contact the contact person to obtain the pt’s new contact information Contact the family physician to obtain the pt’s new contact information or event status

MOTIVATION IS THE BEST ALIANCE FOR AVOID SUBJECTS LOST

PATIENT EDUCATION IS VERY IMPORTANT! Show interest in his or her health and understand the diagnosis Understand the potential impact of the diagnosis Believe that the prescribed treatment will help Know exactly how to take the medication and the duration of therapy Find ways to fit the medication regimen into his or her daily routine Value the outcome of treatment more than the cost of treatment

Levine (1998) demonstrated that the following steps increase adherence: Assessing the person’s understanding about the disease and the treatment regimen and then providing information where knowledge gaps exist Tying the medication-taking process to other daily routines Using adherence aids, such as medication organizers or charts Simplifying medication regimens Providing human support within the health care team Recognizing difficulty in coping and other socio- behavioral issues that may affect the person’s ability to follow the treatment regimen.

DO NOT FORGET! SHARE THE PROBLEMS WITH OUR FRIENDS TO KNOW HOW THEY DO AND SOLVE WHEN HAVE THE SAME SITUATION

/ THANKS A LOT!